Home › Funds › Atwater Malick LLC › DGX

Atwater Malick LLC position in DGX

QUEST DIAGNOSTICS INC · Health Care

Atwater Malick LLC reported holding 29,145 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 1.63% of its reported portfolio and ranking #17 among its reported holdings. Atwater Malick LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)29.14K sh
Reported value held$6.79M
Portfolio Weight1.63%
First reportedQ3 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Atwater Malick LLC's DGX position evolved

Atwater Malick LLC first disclosed a stake in DGX in Q3 2023 at 52,726 shares (US$6.4M). The position peaked in Q2 2025 at 56,666 shares, worth US$10.2M. Across 13 filings, Atwater Malick LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 29,145 shares valued at US$6.8M — a reduction of -412 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 52.73K $6.43M New
Q4 2023 53.97K $7.44M Add
Q1 2024 54.75K $7.29M Add
Q2 2024 54.94K $7.52M Hold
Q3 2024 55.61K $8.63M Add
Q4 2024 55.14K $8.32M Reduce
Q1 2025 56.65K $9.58M Add
Q2 2025 56.67K $10.18M Hold
Q3 2025 42.94K $8.18M Reduce
Q4 2025 35.33K $6.13M Reduce
Q1 2026 30.32K $5.94M Reduce
Q2 2026 29.56K $6.26M Reduce
Q3 2026 29.14K $6.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Atwater Malick LLC held DGX?

Atwater Malick LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Atwater Malick LLC's current position in DGX?

As of Q3 2026, Atwater Malick LLC holds 29.14K shares of DGX (QUEST DIAGNOSTICS INC), valued at $6.79M, representing 1.63% of its reported portfolio and ranking #17.

Has Atwater Malick LLC been buying or selling DGX?

In the latest 13F filing (Q3 2026), Atwater Malick LLC reduced its position in DGX. The position peaked in Q2 2025 at 56.67K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.